Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

MERTK Antikörper

MERTK Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 7E5G1 unconjugated
Produktnummer ABIN966566
  • Target Alle MERTK Antikörper anzeigen
    MERTK (C-Mer Proto-Oncogene Tyrosine Kinase (MERTK))
    Reaktivität
    • 76
    • 38
    • 29
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 70
    • 10
    • 2
    • 1
    Maus
    Klonalität
    • 61
    • 22
    Monoklonal
    Konjugat
    • 49
    • 9
    • 5
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    Dieser MERTK Antikörper ist unkonjugiert
    Applikation
    • 54
    • 45
    • 33
    • 14
    • 12
    • 11
    • 10
    • 9
    • 8
    • 3
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA
    Aufreinigung
    Ascitic fluid
    Immunogen
    Purified recombinant fragment of MER expressed in E. Coli.
    Klon
    7E5G1
    Isotyp
    IgG1
    Top Product
    Discover our top product MERTK Primärantikörper
  • Applikationshinweise
    Western Bloting: 1/500 - 1/2000.
    ELISA: Propose dilution 1/10000.
    Not yet tested in other applications.
    Determining optimal working dilutions by titration test.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C
  • Allouache, Gawande, Tubiana-Hulin, Tubiana-Mathieu, Piperno-Neumann, Mefti, Bozec, Genot: "First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: a phase II study." in: BMC cancer, Vol. 5, pp. 151, (2005) (PubMed).

    Seguineau, Soudant, Moal, Delaporte, Miner, Quéré, Samain: "Techniques for delivery of arachidonic acid to Pacific oyster, Crassostrea gigas, spat." in: Lipids, Vol. 40, Issue 9, pp. 931-9, (2005) (PubMed).

  • Target
    MERTK (C-Mer Proto-Oncogene Tyrosine Kinase (MERTK))
    Andere Bezeichnung
    MER (MERTK Produkte)
    Synonyme
    MER antikoerper, RP38 antikoerper, c-mer antikoerper, Eyk antikoerper, Mer antikoerper, Nyk antikoerper, nmf12 antikoerper, rdy antikoerper, C-EYK antikoerper, MERTK antikoerper, DKFZp469D2215 antikoerper, si:ch1073-268l12.2 antikoerper, MER proto-oncogene, tyrosine kinase antikoerper, c-mer proto-oncogene tyrosine kinase antikoerper, c-mer proto-oncogene tyrosine kinase a antikoerper, MERTK antikoerper, Mertk antikoerper, mertka antikoerper
    Hintergrund
    MER (c-mer proto-oncogene tyrosine kinase) is a member of the MER/AXL/TYRO3 receptor kinase family and encodes a transmembrane protein with two fibronectin type-III domains, two Ig-like C2-type (immunoglobulin-like) domains, and one tyrosine kinase domain. MER has been identified as a tyrosine kinase potentially involved in the development of glioblastomas. It is expressed at highest levels in ovary, prostate, lung and kidney. Gas6, a growth arrest specific gene, and the related anticoagulation factor Protein S have been identified as ligands for the UFO family of receptors. Mutations in this gene have been associated with disruption of the retinal pigment epithelium (RPE) phagocytosis pathway and onset of autosomal recessive retinitis pigmentosa (RP).
    Synonyms: MER, RP38, c-mer, MGC133349, MERTK
    Gen-ID
    10461
    Pathways
    RTK Signalweg
Sie sind hier:
Kundenservice